Influenza A penetrates host mucus by cleaving sialic acids with neuraminidase

Department of Cellular and Molecular Medicine, University of California San Diego, 9500 Gilman Dr, La Jolla 92093, California, USA. .
Virology Journal (Impact Factor: 2.18). 11/2013; 10(1):321. DOI: 10.1186/1743-422X-10-321
Source: PubMed


Influenza A virus (IAV) neuraminidase (NA) cleaves sialic acids (Sias) from glycans. Inhibiting NA with oseltamivir suppresses both viral infection, and viral release from cultured human airway epithelial cells. The role of NA in viral exit is well established: it releases budding virions by cleaving Sias from glycoconjugates on infected cells and progeny virions. The role of NA in viral entry remains unclear. Host respiratory epithelia secrete a mucus layer rich in heavily sialylated glycoproteins; these could inhibit viral entry by mimicking sialylated receptors on the cell surface. It has been suggested that NA allows influenza to penetrate the mucus by cleaving these sialylated decoys, but the exact mechanism is not yet established.
We tested IAV interaction with secreted mucus using frozen human trachea/bronchus tissue sections, and bead-bound purified human salivary mucins (HSM) and purified porcine submaxillary mucins (PSM). The protective effect of mucus was analyzed using MDCK cells coated with purified HSM and PSM with known Sia content. Oseltamivir was used to inhibit NA activity, and the fluorescent reporter substrate, 4MU-Neu5Ac, was used to quantify NA activity.
IAV binds to the secreted mucus layer of frozen human trachea/bronchus tissues in a Sia dependent manner. HSM inhibition of IAV infection is Sia dose-dependent, but PSM cannot inhibit infection of underlying cells. HSM competitively inhibits NA cleavage of 4MU-Neu5Ac, reporter substrate. Human IAV effectively cleaves Sias from HSM but not from PSM, and binds to HSM but not to PSM.
IAV interacts with human mucus on frozen tissue sections and mucus-coated beads. Inhibition of IAV infection by sialylated human mucus is dose-dependent, and enhanced when NA is inhibited with oseltamivir. Thus NA cleaves sialylated decoys during initial stages of infection. Understanding IAV interactions with host mucins is a promising new avenue for drug development.

Download full-text


Available from: Robert Schooley, Mar 01, 2014
  • Source
    • "Defensive mucins are secreted on most animal epithelia. These heavily O-glycosylated glycoproteins resist proteolytic degradation and form hydrated gels, forming a physical barrier against incoming microbes[44]. Mucins can also act as decoys, mimicking the structures of cell surface receptors. Many viruses express sialidases (neuramindases) so that they can bypass sialic acid rich mucin decoys. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Sugars are the most functionally and structurally diverse molecules in the biological world. Glycan structures range from tiny single monosaccharide units to giant chains thousands of units long. Some glycans are branched, their monosaccharides linked together in many different combinations and orientations. Some exist as solitary molecules; others are conjugated to proteins and lipids and alter their collective functional properties. In addition to structural and storage roles, glycan molecules participate in and actively regulate physiological and developmental processes. Glycans also mediate cellular interactions within and between individuals. Their roles in ecology and evolution are pivotal, but not well studied because glycan biochemistry requires different methods than standard molecular biology practice. The properties of glycans are in some ways convenient, and in others challenging. Glycans vary on organismal timescales, and in direct response to physiological and ecological conditions. Their mature structures are physical records of both genetic and environmental influences during maturation. We describe the scope of natural glycan variation and discuss how studying glycans will allow researchers to further integrate the fields of ecology and evolution. Biological Significance. This article introduces methods of discovering glycans and isolating their biological functions. Glycans have dynamic patterns of evolution, and can change in direct response to ecological conditions. We highlight some of the early results of this expansive new field and discuss the many exciting intersections of glycobiology with ecology and evolution.
    Full-text · Article · Nov 2015 · Journal of proteomics
  • Source
    • "Author Email: virion mobility by preventing the virions from sticking to each other and surrounding mucus [14] [45]. Adamantanes reduce the infection rate by blocking uncoating of the influenza virus once it enters the cell, preventing it from ejecting its genetic code into the cell to be transcribed into new virions [1]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Antivirals are the first line of defence against influenza, so drug efficacy should be re-evaluated for each new strain. However, due to the time and expense involved in assessing the efficacy of drug treatments both in vitro and in vivo, treatment regimens are largely not re-evaluated even when strains are found to be resistant to antivirals. Mathematical models of the infection process can help in this assessment, but for accurate model predictions, we need to measure model parameters characterizing the efficacy of antivirals. We use computer simulations to explore whether in vitro experiments can be used to extract drug efficacy parameters for use in viral kinetics models. We find that the efficacy of neuraminidase inhibitors can be determined by measuring viral load during a single cycle assay, while the efficacy of adamantanes can be determined by measuring infected cells during the preparation stage for the single cycle assay.
    Full-text · Article · Jun 2015 · Journal of Biological Dynamics
  • Source
    • "The human influenza virus attaches to the host cell by binding to Neu5Ac-α2,6-Gal-β1,4-GlcNAc (2,6-linked, in short), a sialic acid modification to glycans that is extremely abundant in humans, especially in the epithelial cells of the upper respiratory tract (Skehel & Wiley, 2000). The mucin that protects the cells in the human upper respiratory tract is equally enriched with Neu5Ac-α2,3-Gal (2,3- linked; Cohen et al., 2013), which is recognized by avian strains of influenza virus (Cone, 2009). Both types of sialylglycans are present in different proportions at different regions of the human respiratory tract, and are essential for a success of the infection by influenza-A (Shynia et al., 2006; Nicholls et al., 2007). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The aftermath of influenza infection is determined by a complex set of host-pathogen interactions, where genomic variability on both viral and host sides influences the final outcome. Although there exists large body of literature describing influenza virus variability, only a very small fraction covers the issue of host variance. The goal of this review is to explore the variability of host genes responsible for host-pathogen interactions, paying particular attention to genes responsible for the presence of sialylated glycans in the host endothelial membrane, mucus, genes used by viral immune escape mechanisms, and genes particularly expressed after vaccination, since they are more likely to have a direct influence on the infection outcome.
    Full-text · Article · Sep 2014 · Acta biochimica Polonica
Show more